SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1s16'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AJ6_A_NOVA1_1 (GYRASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	8 / 9	ASN A1042 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ALA A1086 ILE A1090 THR A1163	ANP A1500 (-3.2A) ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None ANP A1500 ( 3.2A) ANP A1500 (-3.7A)	0.70A	1aj6A-1s16A: 24.2	1aj6A-1s16A: 30.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_B_RALB600_1 (ESTROGEN RECEPTOR)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	THR A1264 ALA A1317 LEU A1253 LEU A1230 LEU A1287	None	1.21A	1errB-1s16A: undetectable	1errB-1s16A: 22.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	9 / 12	ASP A1045 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ASP A1077 ILE A1090 ARG A1132 THR A1163	None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.60A	1kijA-1s16A: 41.0	1kijA-1s16A: 40.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	9 / 12	ASN A1042 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ASP A1077 ILE A1090 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.66A	1kijB-1s16A: 41.1	1kijB-1s16A: 40.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KXH_A_ACRA598_2 (ALPHA-AMYLASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	3 / 3	TRP A1255 TYR A1318 LEU A1223	None	0.86A	1kxhA-1s16A: undetectable	1kxhA-1s16A: 21.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	12 / 12	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 PRO A1075 ASP A1077 ILE A1090 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) None None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.41A	1s14A-1s16A: 28.9	1s14A-1s16A: 89.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_A_NOVA1300_1 (TOPOISOMERASE IV SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	ASP A1045 GLU A1046 ASP A1069 ILE A1116 THR A1163	None ANP A1500 (-3.7A) ANP A1500 (-3.5A) ANP A1500 (-4.1A) ANP A1500 (-3.7A)	1.18A	1s14A-1s16A: 28.9	1s14A-1s16A: 89.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S14_B_NOVB2300_1 (TOPOISOMERASE IV SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	12 / 12	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 PRO A1075 ASP A1077 ALA A1086 ILE A1090 ARG A1132	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) None None None ANP A1500 ( 3.2A) None	0.40A	1s14B-1s16A: 28.7	1s14B-1s16A: 89.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q83_A_ADNA1_1 (YTAA PROTEIN)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 7	ILE A1312 ILE A1300 LEU A1301 ILE A1373	None	0.83A	2q83A-1s16A: undetectable	2q83A-1s16A: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEK_B_DIFB1376_1 (ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 7	VAL A1126 GLY A1144 ALA A1121 LEU A1122	None	0.86A	2wekB-1s16A: undetectable	2wekB-1s16A: 23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB303_0 (DISULFIDE INTERCHANGE PROTEIN)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 4	LEU A1035 ALA A1121 VAL A1019 PRO A1023	None	1.07A	3gv1B-1s16A: undetectable	3gv1B-1s16A: 14.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	12 / 12	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 PRO A1075 ASP A1077 ILE A1090 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) None None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.66A	3lpsA-1s16A: 43.1	3lpsA-1s16A: 58.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	ASP A1045 GLU A1046 MET A1074 ILE A1116 THR A1163	None ANP A1500 (-3.7A) ANP A1500 (-4.3A) ANP A1500 (-4.1A) ANP A1500 (-3.7A)	1.39A	3lpsA-1s16A: 43.1	3lpsA-1s16A: 58.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OKX_B_SAMB201_1 (YAEB-LIKE PROTEIN RPA0152)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	LEU A1253 CYH A1316 LEU A1368 PRO A1234 LEU A1287	None	1.34A	3okxB-1s16A: 0.0	3okxB-1s16A: 18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_H_ACTH503_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 7	ALA A1309 ILE A1312 ARG A1292 GLY A1286	None	0.98A	3v4tH-1s16A: undetectable	3v4tH-1s16A: 24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5V_A_ACTA511_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 4	ASN A1033 PHE A1179 SER A1180 GLN A1063	None None SO4 A1502 (-2.6A) None	1.36A	3v5vA-1s16A: 0.3	3v5vA-1s16A: 24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5V_A_ACTA511_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 4	ASN A1269 PHE A1107 SER A1108 GLN A1106	None	1.13A	3v5vA-1s16A: 0.3	3v5vA-1s16A: 24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N49_A_SAMA601_0 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	ALA A1140 GLY A1144 ASN A1143 THR A1027 LEU A1035	None	0.97A	4n49A-1s16A: undetectable	4n49A-1s16A: 22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R20_B_AERB602_1 (CYTOCHROME P450 FAMILY 17 POLYPEPTIDE 2)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 9	PHE A1174 VAL A1019 GLY A1024 THR A1333 VAL A1118	None	1.26A	4r20B-1s16A: undetectable	4r20B-1s16A: 24.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	9 / 11	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 ILE A1090 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) ANP A1500 ( 3.2A) ANP A1500 (-3.7A)	0.97A	4urnA-1s16A: 25.0	4urnA-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	10 / 11	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 PRO A1075 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) None None ANP A1500 (-3.7A)	0.83A	4urnA-1s16A: 25.0	4urnA-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_A_NOVA2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	6 / 11	ASP A1045 GLU A1046 ARG A1072 MET A1074 ILE A1116 THR A1163	None ANP A1500 (-3.7A) None ANP A1500 (-4.3A) ANP A1500 (-4.1A) ANP A1500 (-3.7A)	1.37A	4urnA-1s16A: 25.0	4urnA-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_B_NOVB2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	11 / 11	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 PRO A1075 ILE A1090 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.83A	4urnB-1s16A: 27.2	4urnB-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_B_NOVB2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 11	ASP A1045 GLU A1046 ASP A1069 ILE A1116 THR A1163	None ANP A1500 (-3.7A) ANP A1500 (-3.5A) ANP A1500 (-4.1A) ANP A1500 (-3.7A)	1.29A	4urnB-1s16A: 27.2	4urnB-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_C_NOVC2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	11 / 11	ASN A1042 SER A1043 ASP A1045 GLU A1046 ASP A1069 ARG A1072 MET A1074 PRO A1075 ILE A1090 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) None ANP A1500 (-3.7A) ANP A1500 (-3.5A) None ANP A1500 (-4.3A) None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.80A	4urnC-1s16A: 25.6	4urnC-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URN_C_NOVC2000_1 (DNA TOPOISOMERASE IV, B SUBUNIT)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 11	ASP A1045 GLU A1046 ASP A1069 ILE A1116 THR A1163	None ANP A1500 (-3.7A) ANP A1500 (-3.5A) ANP A1500 (-4.1A) ANP A1500 (-3.7A)	1.27A	4urnC-1s16A: 25.6	4urnC-1s16A: 30.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	9 / 12	ASN A1042 SER A1043 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ASP A1077 ILE A1090 ARG A1132	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None ANP A1500 ( 3.2A) None	0.73A	4uroA-1s16A: 26.1	4uroA-1s16A: 30.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	9 / 12	ASN A1042 SER A1043 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ASP A1077 ILE A1090 ARG A1132	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None ANP A1500 ( 3.2A) None	0.74A	4uroB-1s16A: 26.0	4uroB-1s16A: 30.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	9 / 12	ASN A1042 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ASP A1077 ALA A1086 ILE A1090 ARG A1132	ANP A1500 (-3.2A) ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None None ANP A1500 ( 3.2A) None	0.75A	4uroC-1s16A: 25.9	4uroC-1s16A: 30.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	10 / 12	ASN A1042 SER A1043 GLU A1046 ASP A1069 ARG A1072 PRO A1075 ASP A1077 ILE A1090 ARG A1132 THR A1163	ANP A1500 (-3.2A) ANP A1500 ( 4.0A) ANP A1500 (-3.7A) ANP A1500 (-3.5A) None None None ANP A1500 ( 3.2A) None ANP A1500 (-3.7A)	0.73A	4uroD-1s16A: 25.2	4uroD-1s16A: 30.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YFB_C_PACC601_0 (PROTEIN RELATED TO PENICILLIN ACYLASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	SER A1123 PRO A1169 PHE A1179 HIS A1166 VAL A1126	None	1.29A	4yfbC-1s16A: 0.0	4yfbC-1s16A: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YFB_F_PACF601_0 (PROTEIN RELATED TO PENICILLIN ACYLASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	SER A1123 PRO A1169 PHE A1179 HIS A1166 VAL A1126	None	1.27A	4yfbF-1s16A: 0.0	4yfbF-1s16A: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YFB_I_PACI601_0 (PROTEIN RELATED TO PENICILLIN ACYLASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	SER A1123 PRO A1169 PHE A1179 HIS A1166 VAL A1126	None	1.28A	4yfbI-1s16A: 0.0	4yfbI-1s16A: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YFB_L_PACL601_0 (PROTEIN RELATED TO PENICILLIN ACYLASE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	SER A1123 PRO A1169 PHE A1179 HIS A1166 VAL A1126	None	1.28A	4yfbL-1s16A: 0.0	4yfbL-1s16A: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DV4_A_NMYA601_2 (CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	3 / 3	GLU A1171 TRP A1168 ASN A1143	None	1.09A	5dv4A-1s16A: undetectable	5dv4A-1s16A: 19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EWU_A_BEZA1401_0 (MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 6	GLY A1115 SER A1117 VAL A1118 HIS A1095	ANP A1500 (-3.4A) MG A1501 (-2.9A) None None	1.03A	5ewuA-1s16A: undetectable	5ewuA-1s16A: 23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EWU_B_BEZB1401_0 (MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 6	GLY A1115 SER A1117 VAL A1118 HIS A1095	ANP A1500 (-3.4A) MG A1501 (-2.9A) None None	1.08A	5ewuB-1s16A: undetectable	5ewuB-1s16A: 23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AK3_B_P2EB1201_1 (PROSTAGLANDIN E2 RECEPTOR EP3 SUBTYPE,SOLUBLE CYTOCHROME B562)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	4 / 5	PRO A1272 VAL A1187 GLY A1197 VAL A1044	None	1.11A	6ak3B-1s16A: undetectable	6ak3B-1s16A: 11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F6I_A_8PRA509_1 (ENVELOPE GLYCOPROTEIN,GP,GP1 ENVELOPE GLYCOPROTEIN)	1s16	TOPOISOMERASE IV SUBUNIT B (Escherichia coli)	5 / 12	VAL A1350 LEU A1287 ALA A1353 LEU A1253 LEU A1283	None	1.07A	6f6iA-1s16A: undetectable 6f6iB-1s16A: 0.0	6f6iA-1s16A: 13.85 6f6iB-1s16A: 11.08

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AJ6_A_NOVA1_1","GYRASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",8,"ASN A1042;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ALA A1086;ILE A1090;THR A1163","ANP A1500 (-3.2A);ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;ANP A1500 ( 3.2A);ANP A1500 (-3.7A)","0.70A","1aj6A-1s16A:24.2","1aj6A-1s16A:30.65"],["1ERR_B_RALB600_1","ESTROGEN RECEPTOR","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"THR A1264;ALA A1317;LEU A1253;LEU A1230;LEU A1287","None","1.21A","1errB-1s16A:undetectable","1errB-1s16A:22.67"],["1KIJ_A_NOVA400_1","DNA GYRASE SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",9,"ASP A1045;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ASP A1077;ILE A1090;ARG A1132;THR A1163","None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.60A","1kijA-1s16A:41.0","1kijA-1s16A:40.65"],["1KIJ_B_NOVB444_1","DNA GYRASE SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",9,"ASN A1042;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ASP A1077;ILE A1090;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.66A","1kijB-1s16A:41.1","1kijB-1s16A:40.65"],["1KXH_A_ACRA598_2","ALPHA-AMYLASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",3,"TRP A1255;TYR A1318;LEU A1223","None","0.86A","1kxhA-1s16A:undetectable","1kxhA-1s16A:21.71"],["1S14_A_NOVA1300_1","TOPOISOMERASE IV SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",12,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;PRO A1075;ASP A1077;ILE A1090;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);None;None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.41A","1s14A-1s16A:28.9","1s14A-1s16A:89.40"],["1S14_A_NOVA1300_1","TOPOISOMERASE IV SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"ASP A1045;GLU A1046;ASP A1069;ILE A1116;THR A1163","None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);ANP A1500 (-4.1A);ANP A1500 (-3.7A)","1.18A","1s14A-1s16A:28.9","1s14A-1s16A:89.40"],["1S14_B_NOVB2300_1","TOPOISOMERASE IV SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",12,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;PRO A1075;ASP A1077;ALA A1086;ILE A1090;ARG A1132","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);None;None;None;ANP A1500 ( 3.2A);None","0.40A","1s14B-1s16A:28.7","1s14B-1s16A:89.40"],["2Q83_A_ADNA1_1","YTAA PROTEIN","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"ILE A1312;ILE A1300;LEU A1301;ILE A1373","None","0.83A","2q83A-1s16A:undetectable","2q83A-1s16A:21.48"],["2WEK_B_DIFB1376_1","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"VAL A1126;GLY A1144;ALA A1121;LEU A1122","None","0.86A","2wekB-1s16A:undetectable","2wekB-1s16A:23.15"],["3GV1_B_BEZB303_0","DISULFIDE INTERCHANGE PROTEIN","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"LEU A1035;ALA A1121;VAL A1019;PRO A1023","None","1.07A","3gv1B-1s16A:undetectable","3gv1B-1s16A:14.87"],["3LPS_A_NOVA901_1","TOPOISOMERASE IV SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",12,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;PRO A1075;ASP A1077;ILE A1090;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);None;None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.66A","3lpsA-1s16A:43.1","3lpsA-1s16A:58.92"],["3LPS_A_NOVA901_1","TOPOISOMERASE IV SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"ASP A1045;GLU A1046;MET A1074;ILE A1116;THR A1163","None;ANP A1500 (-3.7A);ANP A1500 (-4.3A);ANP A1500 (-4.1A);ANP A1500 (-3.7A)","1.39A","3lpsA-1s16A:43.1","3lpsA-1s16A:58.92"],["3OKX_B_SAMB201_1","YAEB-LIKE PROTEIN RPA0152","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"LEU A1253;CYH A1316;LEU A1368;PRO A1234;LEU A1287","None","1.34A","3okxB-1s16A:0.0","3okxB-1s16A:18.42"],["3V4T_H_ACTH503_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"ALA A1309;ILE A1312;ARG A1292;GLY A1286","None","0.98A","3v4tH-1s16A:undetectable","3v4tH-1s16A:24.03"],["3V5V_A_ACTA511_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"ASN A1033;PHE A1179;SER A1180;GLN A1063","None;None;SO4 A1502 (-2.6A);None","1.36A","3v5vA-1s16A:0.3","3v5vA-1s16A:24.03"],["3V5V_A_ACTA511_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"ASN A1269;PHE A1107;SER A1108;GLN A1106","None","1.13A","3v5vA-1s16A:0.3","3v5vA-1s16A:24.03"],["4N49_A_SAMA601_0","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"ALA A1140;GLY A1144;ASN A1143;THR A1027;LEU A1035","None","0.97A","4n49A-1s16A:undetectable","4n49A-1s16A:22.44"],["4R20_B_AERB602_1","CYTOCHROME P450 FAMILY 17 POLYPEPTIDE 2","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"PHE A1174;VAL A1019;GLY A1024;THR A1333;VAL A1118","None","1.26A","4r20B-1s16A:undetectable","4r20B-1s16A:24.32"],["4URN_A_NOVA2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",9,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;ILE A1090;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);ANP A1500 ( 3.2A);ANP A1500 (-3.7A)","0.97A","4urnA-1s16A:25.0","4urnA-1s16A:30.50"],["4URN_A_NOVA2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",10,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;PRO A1075;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);None;None;ANP A1500 (-3.7A)","0.83A","4urnA-1s16A:25.0","4urnA-1s16A:30.50"],["4URN_A_NOVA2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",6,"ASP A1045;GLU A1046;ARG A1072;MET A1074;ILE A1116;THR A1163","None;ANP A1500 (-3.7A);None;ANP A1500 (-4.3A);ANP A1500 (-4.1A);ANP A1500 (-3.7A)","1.37A","4urnA-1s16A:25.0","4urnA-1s16A:30.50"],["4URN_B_NOVB2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",11,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;PRO A1075;ILE A1090;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.83A","4urnB-1s16A:27.2","4urnB-1s16A:30.50"],["4URN_B_NOVB2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"ASP A1045;GLU A1046;ASP A1069;ILE A1116;THR A1163","None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);ANP A1500 (-4.1A);ANP A1500 (-3.7A)","1.29A","4urnB-1s16A:27.2","4urnB-1s16A:30.50"],["4URN_C_NOVC2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",11,"ASN A1042;SER A1043;ASP A1045;GLU A1046;ASP A1069;ARG A1072;MET A1074;PRO A1075;ILE A1090;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;ANP A1500 (-4.3A);None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.80A","4urnC-1s16A:25.6","4urnC-1s16A:30.50"],["4URN_C_NOVC2000_1","DNA TOPOISOMERASE IV, B SUBUNIT","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"ASP A1045;GLU A1046;ASP A1069;ILE A1116;THR A1163","None;ANP A1500 (-3.7A);ANP A1500 (-3.5A);ANP A1500 (-4.1A);ANP A1500 (-3.7A)","1.27A","4urnC-1s16A:25.6","4urnC-1s16A:30.50"],["4URO_A_NOVA2000_1","DNA GYRASE SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",9,"ASN A1042;SER A1043;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ASP A1077;ILE A1090;ARG A1132","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;ANP A1500 ( 3.2A);None","0.73A","4uroA-1s16A:26.1","4uroA-1s16A:30.47"],["4URO_B_NOVB2000_1","DNA GYRASE SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",9,"ASN A1042;SER A1043;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ASP A1077;ILE A1090;ARG A1132","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;ANP A1500 ( 3.2A);None","0.74A","4uroB-1s16A:26.0","4uroB-1s16A:30.47"],["4URO_C_NOVC2000_1","DNA GYRASE SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",9,"ASN A1042;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ASP A1077;ALA A1086;ILE A1090;ARG A1132","ANP A1500 (-3.2A);ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;None;ANP A1500 ( 3.2A);None","0.75A","4uroC-1s16A:25.9","4uroC-1s16A:30.47"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",10,"ASN A1042;SER A1043;GLU A1046;ASP A1069;ARG A1072;PRO A1075;ASP A1077;ILE A1090;ARG A1132;THR A1163","ANP A1500 (-3.2A);ANP A1500 ( 4.0A);ANP A1500 (-3.7A);ANP A1500 (-3.5A);None;None;None;ANP A1500 ( 3.2A);None;ANP A1500 (-3.7A)","0.73A","4uroD-1s16A:25.2","4uroD-1s16A:30.47"],["4YFB_C_PACC601_0","PROTEIN RELATED TO PENICILLIN ACYLASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"SER A1123;PRO A1169;PHE A1179;HIS A1166;VAL A1126","None","1.29A","4yfbC-1s16A:0.0","4yfbC-1s16A:21.42"],["4YFB_F_PACF601_0","PROTEIN RELATED TO PENICILLIN ACYLASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"SER A1123;PRO A1169;PHE A1179;HIS A1166;VAL A1126","None","1.27A","4yfbF-1s16A:0.0","4yfbF-1s16A:21.42"],["4YFB_I_PACI601_0","PROTEIN RELATED TO PENICILLIN ACYLASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"SER A1123;PRO A1169;PHE A1179;HIS A1166;VAL A1126","None","1.28A","4yfbI-1s16A:0.0","4yfbI-1s16A:21.42"],["4YFB_L_PACL601_0","PROTEIN RELATED TO PENICILLIN ACYLASE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"SER A1123;PRO A1169;PHE A1179;HIS A1166;VAL A1126","None","1.28A","4yfbL-1s16A:0.0","4yfbL-1s16A:21.42"],["5DV4_A_NMYA601_2","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",3,"GLU A1171;TRP A1168;ASN A1143","None","1.09A","5dv4A-1s16A:undetectable","5dv4A-1s16A:19.86"],["5EWU_A_BEZA1401_0","MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"GLY A1115;SER A1117;VAL A1118;HIS A1095","ANP A1500 (-3.4A); MG A1501 (-2.9A);None;None","1.03A","5ewuA-1s16A:undetectable","5ewuA-1s16A:23.31"],["5EWU_B_BEZB1401_0","MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"GLY A1115;SER A1117;VAL A1118;HIS A1095","ANP A1500 (-3.4A); MG A1501 (-2.9A);None;None","1.08A","5ewuB-1s16A:undetectable","5ewuB-1s16A:23.31"],["6AK3_B_P2EB1201_1","PROSTAGLANDIN E2 RECEPTOR EP3 SUBTYPE,SOLUBLE CYTOCHROME B562","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",4,"PRO A1272;VAL A1187;GLY A1197;VAL A1044","None","1.11A","6ak3B-1s16A:undetectable","6ak3B-1s16A:11.70"],["6F6I_A_8PRA509_1","ENVELOPE GLYCOPROTEIN,GP,GP1;ENVELOPE GLYCOPROTEIN","1s16","TOPOISOMERASE IV SUBUNIT B","Escherichia coli",5,"VAL A1350;LEU A1287;ALA A1353;LEU A1253;LEU A1283","None","1.07A","6f6iA-1s16A:undetectable;6f6iB-1s16A:0.0","6f6iA-1s16A:13.85;6f6iB-1s16A:11.08"]]